# FDA Inspection 1120933 - Sanofi Winthrop Industrie - February 18, 2020

Source: https://www.keypedia.com/records/fda_inspections/sanofi-winthrop-industrie/72018efa-3a51-4b8f-ad0b-598000e372f2
Source feed: FDA_Inspections

> FDA Inspection 1120933 for Sanofi Winthrop Industrie on February 18, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1120933
- Company Name: Sanofi Winthrop Industrie
- Inspection Date: 2020-02-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1227792 - 2024-01-26](https://www.keypedia.com/records/fda_inspections/sanofi-winthrop-industrie/3de20bb5-b52b-4167-be9a-6f65dcbd7be9)
- [FDA Inspection 1223859 - 2023-11-17](https://www.keypedia.com/records/fda_inspections/sanofi-winthrop-industrie/b6dae7b6-1de5-4a55-90f3-3f14c11e72eb)
- [FDA Inspection 1059004 - 2018-07-13](https://www.keypedia.com/records/fda_inspections/sanofi-winthrop-industrie/16482ad2-60b3-4aaf-9744-d4283b47bbaa)
- [FDA Inspection 994790 - 2016-07-28](https://www.keypedia.com/records/fda_inspections/sanofi-winthrop-industrie/4ddbafe5-fa86-46f9-b70c-1c89b92c1ab8)

Company: https://www.keypedia.com/companies/sanofi-winthrop-industrie/f7668868-7954-441c-b8bf-ab135e8645c2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d